The German ADPKD Tolvaptan Treatment Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Cologne
About this trial
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.
Eligibility criteria
Qualifiers
Age > 18 years
ADPKD proven by positive family history and evidence of renal cysts or diagnosed by treating physician
Presentation at our center for tolvaptan treatment indication, or tolvaptan treatment planned, or tolvaptan already started
Disqualifiers
Patients not capable of giving informed consent
End stage renal disease requiring renal replacement therapy
Patients receiving tolvaptan as "off-label use"
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupSponsors and collaborators
University of Cologne
Lead sponsor
University Hospital of Cologne
Sponsor institution
Source ClinicalTrials.gov